Morie Gertz

Mayo Clinic
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (46)

Year:

2026

Year:

2026

Castleman disease (CD) is a heterogeneous group of lymphoproliferative disorders anatomically classified by distribution (unicentric CD [UCD], oligocentric CD [oligoCD], or multicentric CD [MCD]). Human herpes virus 8–negative MCD is called idiopathic MCD (iMCD), which includes clinical subtypes with varying phenotypes and responses: TAFRO (thrombocytopenia, anasarca, fever, renal dysfunction and/or reticulin fibrosis, and organomegaly), IPL (idiopathic plasmacytic lymphadenopathy), and not otherwise specified. OligoCD has recently emerged as an intermediate form between UCD and MCD, with unclear clinical behavior, and IPL has not been validated in a Western cohort. We retrospectively analyzed 217 patients with CD evaluated at our institution between January 2004 and August 2024. Survival probabilities were compared using log-rank tests. Overall, 57% had UCD, 20% had oligoCD, and 23% had iMCD. Patients with oligoCD and iMCD more frequently exhibited systemic symptoms than those with UCD. Patients with oligoCD and iMCD had significantly shorter event-free survival (EFS) of 8.9 and 2.3 years, respectively, than those with UCD (not reached; P< .001 and P< .02). Among iMCD subtypes, iMCD-IPL demonstrated a longer EFS than iMCD-TAFRO (P = .02), with no deaths during the follow-up periods. The results validate oligoCD and iMCD-IPL as new subtypes in this Western cohort. The survival outcome in oligoCD was intermediate between UCD and iMCD, with only a subset of patients with oligoCD requiring systemic therapy. iMCD-IPL had a favorable survival outcome in this US cohort, similar to what has been reported in non-Western countries. Tailoring treatment strategies to disease subtypes and vigilant monitoring of oligoCD for progression may improve survival outcomes in CD.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (30)

Giampaolo Merlini

Director

University of Pavia

ITALY
View details

Esteban Braggio

Assistant Professor

Mayo Clinic

UNITED STATES
View details

Markus Weiler

Prof. Dr

University Hospital Heidelberg

GERMANY
View details

Vaishali Sanchorawala

Boston University School of Medicine

UNITED STATES
View details

Kimon Stamatelopoulos

National and Kapodistrian University of Athens

GREECE
View details

Shaji Kumar

Medical College of Wisconsin

UNITED STATES
View details

Saurabh Chhabra

-

UNITED STATES
View details

David Dingli

Professor of Medicine

Mayo Clinic Minnesota

UNITED STATES
View details

Steven Treon

Professor

Harvard Medical School

UNITED STATES
View details

Yucai Wang

Mayo Clinic Minnesota

UNITED STATES
View details

Marianna Fontana

University College London

UNITED KINGDOM
View details

Alain Delmer

Professor of Hematology

-

FRANCE
View details

Yi Lisa Hwa

Program Director of Mayo Clinic Hematology NP/PA Fellowship , Associate Professor of Medicine

Mayo Clinic Rochester

UNITED STATES
View details

Angela Dispenzieri

Professor / Consultant

Mayo Clinic Minnesota

UNITED STATES
View details

Steven Lentz

Professor

The University of Iowa

UNITED STATES
View details

Terri Menser

Houston Methodist

UNITED STATES
View details

Efstathios Kastritis

Professor

National and Kapodistrian University of Athens

GREECE
View details

Anne Novak

Professor

Mayo Clinic

UNITED STATES
View details

Ute Hegenbart

-

GERMANY
View details

Anita D'Souza

Medical College of Wisconsin

UNITED STATES
View details

Mustaqeem Siddiqui

Assistant Professor

Mayo Clinic

UNITED STATES
View details

Divaya Bhutani

Columbia University

UNITED STATES
View details

Adam Bledsoe

Assistant Professor of Medicine

Mayo Clinic

UNITED STATES
View details

Giovanni Palladini

Director

Università degli Studi di Pavia

ITALY
View details

Marish I. F. J. Oerlemans

Cardiologist

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Monique C. Minnema

-

NETHERLANDS
View details

William Hogan

Mayo Clinic Minnesota

UNITED STATES
View details

S. Vincent Rajkumar

Professor of Medicine

Mayo Clinic Minnesota

UNITED STATES
View details

Jorge Castillo

Clinical Director, Bing Center for Waldenstrom Macroglobulinemia

Dana-Farber Cancer Institute

UNITED STATES
View details

Jonas Paludo

Assistant Professor of Medicine and Oncology

Mayo Clinic

UNITED STATES
View details